posted on Oct, 25 2017 @ 07:05 PM
a reply to:
Phantom423
The fact it mutated is the important part, chances are we can't work out why a historical mutation first occurred. Was it a transcription error? Was
it caused by a chemical or radiation based effect? Did Aliens do it (its ATS I will give the kooks a bone). What is more important than why, more
importantly in these condition causing mutations is the HOW one fixes, or mitagates it.
'
In the case of the various hemoglobin mutations (there be lots) there are multiple mutations, in different spots. Some you never notice, they don't
make the protein do anything too differently, its when you swap a polar for non polar, or rigid bend causing for floppy amino acid, that you get
problems. First year Biochemists study the effects (on the carrier) of this. Because they are simple. Honors students get to research into the more
esoteric ones. I find interactions between genes in the apoptosis scape to be more interesting. They certainly are the best chance to selectively kill
cancers.
As someone who's made (for clients) experimental chemotherapy agents, I'd love to remove the toxic little blighters as the first line defense, and
introduce gene silencing (to use Synthetic lethality) as the go to tool. Anyone who has made a chemotherapy agent,or reads the side effects, knows why
I say this. Cat IV chemicals are no joke.
I'm a scientist in an industry, not academia. My job is to get the result. Only when my API manufacture screws up, do I go after the why. Timelines
and budgets superseed the ivory tower.